Key result
In a mouse model of myocardial infarction, treatment with a superoxide dismutase mimetic salvaged wall thickness by 43% and left ventricular ejection fraction by 27%, and increased survival.
Why the study?
Does treatment with a superoxide dismutase mimetic improve bone marrow progenitor cell engraftment and cardiac remodeling after myocardial infarction in mice?
Does treatment with a superoxide dismutase mimetic improve bone marrow progenitor cell engraftment and cardiac remodeling after myocardial infarction in mice?
Antioxidant treatment with a superoxide dismutase mimetic improves bone marrow progenitor cell engraftment, preserves cardiac function, and increases survival after myocardial infarction in mice.
May inform antioxidant strategies for post-MI remodeling in mice; hypothesis-generating and leaves clinical translation open.
BACKGROUND: The core region of a myocardial infarction is notoriously unsupportive of cardiomyocyte survival. However, there has been less investigation of the potentially beneficial spontaneous recruitment of endogenous bone marrow progenitor cells (BMPCs) within infarcted areas. In the current study we examined the role of tissue oxygenation and derived toxic species in the control of BMPC engraftment during postinfarction heart remodeling. METHODS AND RESULTS: For assessment of cellular origin, local oxygenation, redox status, and fate of cells in the infarcted region, myocardial infarction in mice with or without LacZ(+) bone marrow transplantation was induced by coronary ligation. Sham-operated mice served as controls. After 1 week, LacZ(+) BMPC-derived cells were found inhomogeneously distributed into the infarct zone, with a lower density at its core. Electron paramagnetic resonance (EPR) oximetry showed that pO2 in the infarct recovered starting on day 2 post-myocardial infarction, concomitant with wall thinning and erythrocytes percolating through muscle microruptures. Paralleling this reoxygenation, increased generation of reactive oxygen/nitrogen species was detected at the infarct core. This process delineated a zone of diminished BMPC engraftment, and at 1 week infiltrating cells displayed immunoreactive 3-nitrotyrosine and apoptosis. In vivo treatment with a superoxide dismutase mimetic significantly reduced reactive oxygen species formation and amplified BMPC accumulation. This treatment also salvaged wall thickness by 43% and left ventricular ejection fraction by 27%, with significantly increased animal survival. CONCLUSIONS: BMPC engraftment in the infarct inversely mirrored the distribution of reactive oxygen/nitrogen species. Antioxidant treatment resulted in increased numbers of engrafted BMPCs, provided functional protection to the heart, and decreased the incidence of myocardial rupture and death.
No takes yet. Share an insight, caveat, or question.
Moldovan et al. (2014) studied Myocardial infarction. Superoxide dismutase mimetic vs. Sham-operated or untreated controls was evaluated on Bone marrow progenitor cell engraftment, wall thickness, left ventricular ejection fraction, and survival. In a mouse model of myocardial infarction, treatment with a superoxide dismutase mimetic salvaged wall thickness by 43% and left ventricular ejection fraction by 27%, and increased survival.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: